David A. Garrison - 30 Jan 2024 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship: Chief Financial Officer
Issuer ticker: HHS
Reported as of: 30 Jan 2024
Net transaction value: +$500,004
SEC form: 4
Accepted by SEC: 01 Feb 2024, 15:41:32 UTC
Prior SEC filing: 17 Nov 2023
Next SEC filing: 13 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Robert Wyman, Attorney-in-fact for David A Garrison

Key filing fact

David A. Garrison filed Form 4 for HARTE HANKS INC (HHS) on 01 Feb 2024.

Key facts

This page summarizes David A. Garrison's Form 4 filing for HARTE HANKS INC (HHS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Feb 2024, 15:41.

Change

Previous filing in this sequence was filed on 17 Nov 2023.
Current net transaction value: +$500,004.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HHS transaction Derivative

Option to buy Common Shares

Award

Transaction value: $500,004
Shares: +64,600
Change %
Price: $7.74
Shares after: 64,600
Date: 30 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 64,600
Exercise price: $7.74
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

1/3 of options vests annually on January 29, beginning in 2025 and ending in 2027.